NP91618c Interferon Beta-1a (Avonex®)
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Region | Scotland |
| Procedure | limited |
| OCID | ocds-h6vhtk-02f99f |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Biogen Idec Ltd. | · | · | active |
description
The Framework Agreement is for the supply of Interferon Beta-1a (Avonex®) to NHS Scotland.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 24 Nov 2021 | Voluntary ex-ante transparency (F15) | Earlier regulations | 029232-2021 |
| 8 Jul 2022 | Voluntary ex-ante transparency (F15) | Earlier regulations | 018778-2022 |
more from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
- Islet Cell Processing Systems · 22 Jul 2026
- C002181 Building on the NES Education and Career Pathway for Adult Integrated Community Nursing in Scotland. · 17 Jul 2026
- Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables · £140,000,000 · 9 Jul 2026
- Cleaning Wipe Products Surface and Patient · £18,800,000 · 12 Jun 2026
- Cath Labs and Cardiology Stents · £40,800,000 · 12 Jun 2026
- NP57026 Disposable Medical Pulp and Associated Products · £11,406,834 · 11 Jun 2026
- Orthotic Consumables · £1,600,000 · 26 May 2026
- NP36126 Antibiotic & Genito Urinary Medicines · £88,941,093 · 25 May 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.